1. Home
  2. DLO vs ICUI Comparison

DLO vs ICUI Comparison

Compare DLO & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DLO
  • ICUI
  • Stock Information
  • Founded
  • DLO 2013
  • ICUI 1984
  • Country
  • DLO Uruguay
  • ICUI United States
  • Employees
  • DLO N/A
  • ICUI N/A
  • Industry
  • DLO Business Services
  • ICUI Medical/Dental Instruments
  • Sector
  • DLO Consumer Discretionary
  • ICUI Health Care
  • Exchange
  • DLO Nasdaq
  • ICUI Nasdaq
  • Market Cap
  • DLO 3.2B
  • ICUI 3.4B
  • IPO Year
  • DLO 2021
  • ICUI 1992
  • Fundamental
  • Price
  • DLO $10.01
  • ICUI $127.40
  • Analyst Decision
  • DLO Buy
  • ICUI Strong Buy
  • Analyst Count
  • DLO 9
  • ICUI 5
  • Target Price
  • DLO $12.18
  • ICUI $196.75
  • AVG Volume (30 Days)
  • DLO 1.1M
  • ICUI 186.2K
  • Earning Date
  • DLO 08-13-2025
  • ICUI 08-07-2025
  • Dividend Yield
  • DLO 5.10%
  • ICUI N/A
  • EPS Growth
  • DLO 9.51
  • ICUI N/A
  • EPS
  • DLO 0.48
  • ICUI N/A
  • Revenue
  • DLO $778,303,000.00
  • ICUI $2,420,093,000.00
  • Revenue This Year
  • DLO $30.91
  • ICUI N/A
  • Revenue Next Year
  • DLO $26.57
  • ICUI N/A
  • P/E Ratio
  • DLO $20.83
  • ICUI N/A
  • Revenue Growth
  • DLO 11.59
  • ICUI 7.22
  • 52 Week Low
  • DLO $6.58
  • ICUI $117.92
  • 52 Week High
  • DLO $14.27
  • ICUI $196.26
  • Technical
  • Relative Strength Index (RSI)
  • DLO 35.14
  • ICUI 46.81
  • Support Level
  • DLO $10.63
  • ICUI $124.39
  • Resistance Level
  • DLO $11.16
  • ICUI $134.04
  • Average True Range (ATR)
  • DLO 0.39
  • ICUI 3.75
  • MACD
  • DLO -0.13
  • ICUI 0.18
  • Stochastic Oscillator
  • DLO 12.82
  • ICUI 47.55

About DLO DLocal Limited

DLocal Ltd is focused on making the complex simple, redefining the online payment experience in emerging markets. Through its technology platform, One dLocal, the company enables world-wide enterprise merchants to get paid (pay-in) and to make payments (pay-out) online in a safe and efficient manner. The company earns revenue from fees charged to merchants in connection with payment processing services for cross-border and local payment transactions. The company's geographical segments include Latin America and Non-Latin America with a majority of its revenue being generated from Brazil in Latin America region.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

Share on Social Networks: